TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,148 | -25.7% | 7,324 | -24.4% | 0.00% | – |
| Q2 2023 | $175,080 | +247.3% | 9,689 | +141.6% | 0.00% | – |
| Q1 2023 | $50,406 | +16.8% | 4,010 | +36.3% | 0.00% | – |
| Q4 2022 | $43,144 | -18.6% | 2,943 | -5.2% | 0.00% | – |
| Q3 2022 | $53,000 | +17.8% | 3,106 | +2.0% | 0.00% | – |
| Q2 2022 | $45,000 | -43.0% | 3,045 | -35.4% | 0.00% | – |
| Q1 2022 | $79,000 | -54.1% | 4,713 | -38.4% | 0.00% | – |
| Q4 2021 | $172,000 | -18.1% | 7,654 | -21.8% | 0.00% | – |
| Q3 2021 | $210,000 | +233.3% | 9,784 | +404.1% | 0.00% | – |
| Q1 2021 | $63,000 | -52.3% | 1,941 | -39.2% | 0.00% | – |
| Q4 2020 | $132,000 | – | 3,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |